Published in Am J Pathol on September 01, 2004
Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med (2007) 2.14
Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia (2007) 1.86
Modulation of canonical Wnt signaling by the extracellular matrix component biglycan. Proc Natl Acad Sci U S A (2011) 1.85
PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem (2009) 1.51
Wnt signaling and injury repair. Cold Spring Harb Perspect Biol (2012) 1.30
CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins. J Cell Biochem (2006) 1.26
WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J Bone Miner Res (2011) 1.23
Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin Ther Targets (2012) 1.14
Mechanical activation of β-catenin regulates phenotype in adult murine marrow-derived mesenchymal stem cells. J Orthop Res (2010) 1.12
Biglycan: a multivalent proteoglycan providing structure and signals. J Histochem Cytochem (2012) 1.12
The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol (2010) 1.11
Mechanical stimulation alters tissue differentiation and molecular expression during bone healing. J Orthop Res (2009) 1.09
CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway. J Biol Chem (2010) 1.05
Macrophages modulate adult zebrafish tail fin regeneration. Development (2014) 1.05
CCN5 expression in mammals : I. Embryonic and fetal tissues of mouse and human. J Cell Commun Signal (2007) 1.04
TGF-beta1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function. J Cell Biochem (2008) 1.03
Beta-catenin--a supporting role in the skeleton. J Cell Biochem (2010) 0.99
Wnt signaling during fracture repair. Curr Osteoporos Rep (2009) 0.98
Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis. Endocrinology (2009) 0.97
WISP1 (CCN4) autoregulates its expression and nuclear trafficking of β-catenin during oxidant stress with limited effects upon neuronal autophagy. Curr Neurovasc Res (2012) 0.95
WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone. PLoS One (2013) 0.95
Wnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xL. Curr Neurovasc Res (2012) 0.95
WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1. Curr Neurovasc Res (2013) 0.91
Association of a single nucleotide polymorphism in the WISP1 gene with spinal osteoarthritis in postmenopausal Japanese women. J Bone Miner Metab (2007) 0.91
The potential functional interaction of biglycan and WISP-1 in controlling differentiation and proliferation of osteogenic cells. Cells Tissues Organs (2008) 0.90
Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia. Curr Neurovasc Res (2013) 0.90
Wnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern β-amyloid apoptotic injury of microglia. Curr Neurovasc Res (2012) 0.88
WISP1: Clinical insights for a proliferative and restorative member of the CCN family. Curr Neurovasc Res (2014) 0.88
Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). Int J Mol Med (2015) 0.88
Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women. Bone (2010) 0.86
The 5' untranslated regions (UTRs) of CCN1, CCN2, and CCN4 exhibit cryptic promoter activity. J Cell Commun Signal (2007) 0.85
Osteoblast-derived WNT-induced secreted protein 1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126. Oncotarget (2014) 0.84
Temporal and spatial expression of CCN genes in zebrafish. Dev Dyn (2010) 0.84
CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis. J Cell Commun Signal (2012) 0.83
Will o' the wisp: CCN4 as a novel molecular target in osteoarthritis. J Cell Commun Signal (2010) 0.82
Input of microenvironmental regulation on colorectal cancer: role of the CCN family. World J Gastroenterol (2014) 0.82
Attenuation of chondrogenic transformation in vascular smooth muscle by dietary quercetin in the MGP-deficient mouse model. PLoS One (2013) 0.81
The role of CCN family genes in haematological malignancies. J Cell Commun Signal (2015) 0.81
WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling. J Biol Chem (2015) 0.80
Age-related changes in cochlear gene expression in normal and shaker 2 mice. J Assoc Res Otolaryngol (2006) 0.80
Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities. Hum Genomics (2015) 0.80
Does Sclerostin Depletion Stimulate Fracture Healing in a Mouse Model? Clin Orthop Relat Res (2015) 0.79
Picking a bone with WISP1 (CCN4): new strategies against degenerative joint disease. J Transl Sci (2016) 0.78
Polymorphic variation of hypoxia inducible factor-1 A (HIF1A) gene might contribute to the development of knee osteoarthritis: a pilot study. BMC Musculoskelet Disord (2015) 0.78
Matricellular proteins of the Cyr61/CTGF/NOV (CCN) family and the nervous system. Front Cell Neurosci (2015) 0.77
Fracture healing and drug therapies in osteoporosis. Clin Cases Miner Bone Metab (2009) 0.76
Mice with a heterozygous Lrp6 deletion have impaired fracture healing. Bone Res (2016) 0.75
Emerging roles of CCN proteins in vascular development and pathology. J Cell Commun Signal (2016) 0.75
WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel Disease. Dis Markers (2016) 0.75
Osteoblastic cells regulate the haematopoietic stem cell niche. Nature (2003) 19.60
Wnt signaling and cancer. Genes Dev (2000) 18.53
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Developmental regulation of the growth plate. Nature (2003) 11.53
Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol (1998) 9.24
Reaching a genetic and molecular understanding of skeletal development. Dev Cell (2002) 7.55
Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. Science (2000) 7.25
Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem (1999) 6.54
Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol (1994) 5.93
Control of osteoblast function and regulation of bone mass. Nature (2003) 5.06
CCN proteins: multifunctional signalling regulators. Lancet (2004) 4.88
Wnt genes. Cell (1992) 4.55
Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A (2002) 4.46
Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol (2002) 4.23
Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol (2002) 4.14
The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett (1993) 3.99
The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res (1999) 3.90
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J (2000) 3.81
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73
The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev (1999) 3.45
Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol (1995) 3.44
Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am (2003) 3.36
NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol (2001) 3.27
Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell (2001) 3.06
Thrombospondins as matricellular modulators of cell function. J Clin Invest (2001) 2.95
Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res (1999) 2.94
CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol (2002) 2.94
Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem (1990) 2.72
WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev (2000) 2.67
Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development (2000) 2.61
Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest (2002) 2.59
Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology (2002) 2.46
Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. J Biol Chem (1985) 2.39
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet (1999) 2.23
The complexities of skeletal biology. Nature (2003) 2.21
Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res (2002) 2.08
Deciphering skeletal patterning: clues from the limb. Nature (2003) 2.00
The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J Biol Chem (2002) 1.91
Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res (1997) 1.88
Proteoglycans of developing bone. J Biol Chem (1983) 1.86
Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech Dev (1998) 1.86
Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis (2002) 1.84
WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev (2002) 1.80
Epithelial mesenchymal interactions in cancer and development. Cell (2001) 1.77
Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol (2002) 1.75
The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem (2001) 1.73
Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J Biol Chem (2002) 1.73
The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling. Proc Natl Acad Sci U S A (1999) 1.69
The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis. Dev Biol (2002) 1.68
Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med (1992) 1.67
Interaction of biglycan with type I collagen. J Biol Chem (1995) 1.63
BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem (2002) 1.53
Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol (2000) 1.51
p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp Cell Res (1999) 1.43
CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain. J Biol Chem (2001) 1.43
Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol (2003) 1.43
Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev Biol (1997) 1.39
Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61). J Biol Chem (2003) 1.38
Inhibition of chondrogenesis by Wnt gene expression in vivo and in vitro. Dev Biol (1997) 1.37
Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development. Cell Growth Differ (1992) 1.36
Wnt genes and vertebrate development. Curr Opin Genet Dev (1994) 1.35
The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol (2002) 1.35
A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma. Oncogene (2001) 1.33
WISP-1 binds to decorin and biglycan. J Biol Chem (2001) 1.32
Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro. Growth Factors (1998) 1.32
Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res (2002) 1.29
Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine (2001) 1.20
CTGF expression during mouse embryonic development. Cell Tissue Res (2003) 1.18
Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol (1991) 1.16
Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J Biol Chem (1999) 1.14
Critical role of glutamate in a central leucine-rich repeat of decorin for interaction with type I collagen. J Biol Chem (1997) 1.06
Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol Cell Biol (1996) 1.06
Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling. J Biol Chem (2002) 1.03
A comparison of the expression pattern of five genes of the family of small leucine-rich proteoglycans during mouse development. J Bone Miner Res (2000) 1.01
Gene expression during bone repair. Clin Orthop Relat Res (1993) 1.00
Binding of collagen XIV with the dermatan sulfate side chain of decorin. J Biol Chem (1993) 0.98
Matricellular proteins: an overview. Matrix Biol (2000) 0.98
Modulation of commitment, proliferation, and differentiation of chondrogenic cells in defined culture medium. Endocrinology (1997) 0.97
Expression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 (CTGF/Hcs24) during fracture healing. Bone (2002) 0.95
Epithelial mesenchymal interactions, the ECM and limb development. J Anat (2003) 0.94
Correlation of expression of Wnt-1 in developing limbs with abnormalities in growth and skeletal patterning. Nature (1993) 0.83
Novel non-isotopic method for the localization of receptors in tissue sections. J Histochem Cytochem (2001) 0.82
[Application of the warm heart surgery to the open heart surgery in children]. Nihon Kyobu Geka Gakkai Zasshi (1994) 0.76
The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature (2004) 5.05
Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A (2002) 4.46
Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer. J Clin Oncol (2005) 4.02
Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell (2008) 2.35
Angiogenesis and bone repair. Drug Discov Today (2003) 2.26
A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol (2002) 2.02
TGF-beta regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci U S A (2005) 1.83
Effects of orientation-specific visual deprivation induced with altered reality. Curr Biol (2009) 1.57
Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. PLoS One (2007) 1.44
Loss of the serine/threonine kinase fused results in postnatal growth defects and lethality due to progressive hydrocephalus. Mol Cell Biol (2005) 1.39
Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res (2005) 1.36
COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas. Cancer Res (2004) 1.35
Tumor-driven paracrine platelet-derived growth factor receptor alpha signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma. Clin Cancer Res (2006) 1.29
Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice. Endocrinology (2002) 1.13
EphB2 is a prognostic factor in colorectal cancer. Clin Cancer Res (2005) 1.11
Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4. MAbs (2011) 1.06
Control of NKT cell differentiation by tissue-specific microenvironments. J Immunol (2003) 1.05
Cutting edge: novel human dendritic cell- and monocyte-attracting chemokine-like protein identified by fold recognition methods. J Immunol (2006) 1.04
Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF). J Pathol (2005) 1.04
Myodegeneration in EDA-A2 transgenic mice is prevented by XEDAR deficiency. Mol Cell Biol (2004) 1.03
Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2014) 1.02
Age-dependent brain activation during forward and backward digit recall revealed by fMRI. Neuroimage (2005) 1.01
GEPIS--quantitative gene expression profiling in normal and cancer tissues. Bioinformatics (2004) 0.96
Genetic variability within and among Haemonchus contortus isolates from goats and sheep in China. Parasit Vectors (2013) 0.88
Creation and characterization of a mouse model of mandibular distraction osteogenesis. Bone (2004) 0.88
Quantitative in situ hybridization of tissue microarrays. Methods Mol Biol (2006) 0.86
Spontaneous recovery of motion and face aftereffects. Vision Res (2013) 0.83
Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown. J Rheumatol (2002) 0.82
Attention shift in human verbal working memory: priming contribution and dynamic brain activation. Brain Res (2006) 0.80
Viable tumor tissue detection in murine metastatic breast cancer by whole-body MRI and multispectral analysis. Magn Reson Med (2009) 0.79
Computer games: a double-edged sword? Cyberpsychol Behav (2008) 0.78
Age-related differences in the accumulation and size of hyaluronan in alginate culture. Arch Biochem Biophys (2002) 0.78
Direct printing of patterned three-dimensional ultrafine fibrous scaffolds by stable jet electrospinning for cellular ingrowth. Biofabrication (2015) 0.78
The time course of contrast adaptation measured with a new method: detection of ramped contrast. Perception (2014) 0.77
A plant kinase plays roles in defense response against geminivirus by phosphorylation of a viral pathogenesis protein. Plant Signal Behav (2012) 0.76
Puerarin protects against Staphylococcus aureus-induced injury of human alveolar epithelial A549 cells via downregulating alpha-hemolysin secretion. Microb Drug Resist (2013) 0.75
Treatment of epilepsy with bipolar electro-coagulation: an analysis of cortical blood flow and histological change in temporal lobe. Chin Med J (Engl) (2015) 0.75
Exploring timescales of adaptation mechanisms along the visual-processing hierarchy. J Vis (2015) 0.75
Detection of multiple clustered microcalcifications by mammography following breast-conserving surgery. Chin Med J (Engl) (2010) 0.75
Molecular cloning and mRNA expression of duck invariant chain. Vet Immunol Immunopathol (2005) 0.75
[Functional recovery of rat facial-facial anastomosis model]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2008) 0.75
Collagen gels with different fibrillar microarchitectures elicit different cellular responses. ACS Appl Mater Interfaces (2017) 0.75
Interocular grouping of negative afterimages after binocular rivalry. J Vis (2015) 0.75
Robust Size Illusion Produced by Expanding and Contracting Flow Fields. J Vis (2015) 0.75
Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways. J Alzheimers Dis (2016) 0.75